Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/9648
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParpibaeva Dinara Ayupovna., Salayeva Muborak Saidabdullayevna., Salimova Nargiza Djurabaevna., Ergashov Nodirbek Shermuxamat o’g’li., Buvamuxamedova Nasiba Taxirovna-
dc.date.accessioned2023-12-12T12:40:10Z-
dc.date.available2023-12-12T12:40:10Z-
dc.date.issued2023-
dc.identifier.issn2751-1731-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/9648-
dc.description.abstractToday, diabetes mellitus is considered a “pandemic”, and the number of patients with this disease and its complications is increasing day by day. Diabetes mellitus is a severe complication of diabetic retinopathy that leads to blindness and disability in people. Timely detection, prevention and effective treatment of this complication are among the urgent tasks facing endocrinologists. Today, taking into account such risk factors as hyperglycemia, dyslipidemia and uncontrolled arterial hypertension, which play a leading role in the pathogenesis of complications of diabetic retinopathy, many studies are being carried out in the world on the effective complex treatment of this complication. This article talks about the next study conducted at the multidisciplinary clinic of the Tashkent Medical Academy.en_US
dc.language.isoen_USen_US
dc.publisherSpectrum Journal of Innovation, Reforms and Developmenen_US
dc.subjectDM - Diabetes mellitus, Diabetic retinopathy, Dyslipidemia, Fenofibrate (Tricor).en_US
dc.titleFENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHYen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
10. Ergashov N.Sh..pdfFENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHY289.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.